A decrease in the ability of the bone marrow cells to produce blood cells, including red blood cells, white blood cells and platelets. This condition increases susceptibility to infection and produces fatigue.
Since myelosuppression and generalized immunosuppression are an anticipated consequence of both leukemia and its treatment with chemotherapy , it is imperative that patients be closely monitored during treatment.